It’s imperative to devote more resources to infectious-disease control, leading to the development of new antibiotics. In 2015, the U.S. White House launched a national action plan against antimicrobial resistance (AMR), also commonly known as antibiotic resistance. In 2017, the World Health Organization (WHO) announced the 12 types of highly resistant bacteria that pose the…

The Novartis motto – “Reimagining Medicine” – goes to the heart of the company’s deep commitment to developing innovative drugs to help fill the unmet needs of patients worldwide. The Swiss-based pharmaceutical multinational consistently ranks among the top companies investing in R&D, ensuring a constant pipeline of new and groundbreaking treatments. In 2017 the investment…

Transforming Taiwan into a regional biomedical hub will require some creativity. Taiwan’s biomedicine industry has many of the ingredients for success. The island has strong scientific talent, rich clinical-trial experience, abundant capital, a treasure trove of medical data (from the National Health Insurance system), information-technology expertise, and strong intellectual property rights protection bolstered by the…

Dr. Wang Ying-wei, head of the Health Promotion Administration, giving a presentation

The government’s Health Promotion Administration seeks to reduce the toll from noncommunicable diseases. Communicable diseases such as Zika, dengue fever, and Ebola may grab headlines and inspire fear, but in developed countries such as Taiwan, it is slower-moving but highly destructive noncommunicable diseases (NCDs) that are the biggest threat to both lives and the economy….